References
[1]Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk[J]. JAMA, 1998, 279(8): 593-598.
[2]Clinical and Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing-Approved Standard.M2-A9. Clinical and Laboratory Standard Institute: Wayne PA 2005.
[3]Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2002, 46(7): 21552161.
[4]Lina G, Piémont Y, GodailGamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia[J]. Clin Infect Dis, 1999, 29(5): 1128-1132.
[5]Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2000, 44(6): 1549-1555.
[6]Ma XX, Ito T, Tiensasitorn C, Jamklang M, Chongtrakool P, Boyle-Vavra S, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains[J]. Antimicrob Agents Chemother, 2002, 46(4): 1147-1152.
[7]Nakamura MM, Rohling KL, Shashaty M, Lu H, Tang YW, Edwards KM. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population[J]. Pediatr Infect Dis, 2002, 21(10):917-922.
[8]Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities[J].N Engl J Med, 2005, 352(14): 1436-1444.
[9]Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles[J]. N Engl J Med, 2005, 352(14): 1445-1453.
[10]Frank AL, Marcinak JF, Mangat PD, Schreckenberger PC. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in childre[J]. Pediatr Infect Dis, 1999, 18(11): 993-1000.
[11]Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus noncarriers[J]. Lancet, 2004, 364(9435): 703-705.
[12]Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus[J]. J Clin Microbiol, 2000, 38(3): 1008-1015.
[13]Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC[J]. Antimicrob Agents Chemother, 2004, 48(7): 2637-2651.
[14]Boyle-Vavra S, Ereshefsky B, Wang CC, Daum RS. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV[J]. J Clin Microbiol, 2005, 43(9): 4719-4730.
[15]Iyer S, Jones DH. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak[J]. J Am Acad Dermatol, 2004, 50(6): 854-858.
[16]Yu F, Chen Z, Liu C, Zhang X, Lin X, Chi S, et al. Prevalence of Staphylococcus aureus carrying Panton-Valentine leukocidin genes among isolates from hospitalised patients in China[J]. Clin Microbiol Infect, 2008, 14(4): 381-384.
[17]Fan J, Shu M, Zhang G, Zhou W, Jiang Y, Zhu Y, et al. Biogeography and virulence of Staphylococcus aureus[J]. PLoS One, 2009, 4(7): e6216.